Delivery Order SPE2DB24D3013-SPE2DB25FFNYD
Award Date 8/1/25
Potential Completion Date 8/4/25
Potential Value $5.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency valued at $6,018.43 for the supply of Ozempic (semaglutide) 0.25–0.5 mg/dose pens in 3 mL vials. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 12, 2025. The pharmaceutical product will be distributed from the vendor's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitively-procured delivery order by the Defense Logistics Agency on August 27, 2025, for the supply of Ozempic (semaglutide) 1 mg/dose in 4 mg/3 mL vials. The contract, valued at $24,624.71 with a firm fixed price structure, is set to complete by August 28, 2025, and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 5, 2025, for Ozempic 0.25-0.5 mg/dose pens (3ml) with a ceiling value of $1,001.98. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 6, 2025. The place of performance is located at the company's corporate office in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on June 4, 2025, by the Defense Logistics Agency (DLA) for the supply of Ozempic 0.25–0.5 mg/dose pens (3 mL). The contract, valued at $7,888.63, is structured as a firm fixed-price delivery order with no set-aside designation, reflecting competitive award procedures. Performance will be completed at the vendor's Conshohocken facility by the ultimate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency (DLA) on August 20, 2025, valued at $9,486.77. The contract calls for the delivery of Ozempic 0.25–0.5 mg/dose pens (3 mL) to support federal medical supply requirements. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and is scheduled for ultimate completion by August 21, 2025, with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) for Ozempic 0.25–0.5 mg/dose pens (3 mL) valued at $7,440.06. Awarded on July 28, 2025, with a firm fixed price structure and ultimate completion date of July 29, 2025, this competitively awarded contract includes no set-aside designation. The place of performance is located at the contractor's corporate office in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency valued at $10,069.95 for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml). The contract, awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, carries a firm fixed price structure and was not designated as a set-aside award. Performance will be executed at AmerisourceBergen's corporate office location...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 21, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed-price delivery order has a ceiling value of $28,322.36 and an ultimate completion date of July 22, 2025. The contract carries no set-aside designation, indicating it was competed among qualified vendors through open...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Ozempic (semaglutide) 0.25–0.5 mg/dose pens in 3 mL formulations. This competitively awarded, non-set-aside delivery order carries a ceiling value of $32,930.62 under firm fixed-price terms, with an ultimate completion date of August 19, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency valued at $1,879.98 for Ozempic 0.25-0.5 mg/dose pens in 3 mL vials. The contract is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 28, 2025. This award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as...